Clinical Effectiveness Research Group, University Hospital of Oslo, University of Oslo, Oslo, Norway.
Clinical Effectiveness Research Group, University Hospital of Oslo, University of Oslo, Oslo, Norway -
Minerva Surg. 2023 Feb;78(1):81-85. doi: 10.23736/S2724-5691.22.09810-0.
Upper gastrointestinal cancers (i.e., esophageal and gastric cancers) are common cancers worldwide with high mortality and morbidity. Although there is no randomized controlled trial-based evidence, early detection with endoscopy is expected to positively affect prognosis and morbidity. However, endoscopic procedures are always accompanied by human-induced errors such as overlooking of neoplasia and cancers. Recently, the use of artificial intelligence (AI) during upper gastrointestinal endoscopy is catching attention because it is expected to reduce human-induced variability of the examination. This review article introduces the overview of the expectation and current status of the AI tools for upper gastrointestinal endoscopy and shares possible challenges and corresponding solutions with readers.
上消化道癌症（即食管癌和胃癌）是一种在全球范围内发病率和死亡率都很高的常见癌症。尽管没有基于随机对照试验的证据，但通过内窥镜进行早期检测有望对预后和发病率产生积极影响。然而，内窥镜检查总是伴随着人为错误，如忽视肿瘤和癌症。最近，人工智能（AI）在上消化道内窥镜检查中的应用引起了人们的关注，因为它有望减少检查中的人为可变性。本文综述了上消化道内窥镜 AI 工具的预期和现状，并与读者分享了可能存在的挑战和相应的解决方案。
